{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9NZQ7",
      "entity_text" : "PD-L1",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Further studies on sequential / cyclic combinations of these immunotherapies with consideration of immunologically relevant parameters (e.g., PD-L1 expression levels, BRAF/NRAS/cKIT mutation analysis), tumor typing and staging, and patient characteristics (e.g., age, comorbidities, treatment history) are ongoing [XREF_BIBR].",
  "reading_complete" : "2020-08-04T13:55:48Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T13:47:45Z",
  "trigger" : "levels",
  "evidence" : [ "PD-L1 expression levels" ],
  "pmc_id" : "5289116",
  "score" : 0
}